Lv1
20 积分 2025-12-19 加入
AR-targeted therapies sensitize prostate cancer to cuproptosis by transcriptionally activating FDX1
3小时前
待确认
Targeted delivery of elesclomol using a magnetic mesoporous platform improves prostate cancer treatment both in vitro and in vivo
7小时前
已完结
A cuproptosis nanocapsule for cancer radiotherapy
2个月前
已完结
皖公网安备34019202002308
